The transition from vocational education and training to higher education: A successful pathway? by Hoelscher, M, Hayward, G, Ertl, H, Dunbar-Goddet, H

The transition from vocational education and training to higher education: a successful pathway? by Hoelscher, M, Hayward, G, Ertl, H, Dunbar-Goddet, H

UNITE4TB: a new consortium for clinical drug and regimen development for TB by Boeree, MJ, Lange, C, Thwaites, G, Paton, N, de Vrueh, R, Barros, D, Hoelscher, M

Characterization of envelope function of transmitted viruses circulating in Mbeya, Tanzania, and its impact on disease progression by Nofemela A, Bandawe G, Thebus R, Marais J, Maboko L, Hoelscher M, Williamson C, Woodman Z

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania by Mann PJ, Munseri P, Kaluwa B, Missanga M, Lwakatare J, Hoelscher M, Bakari M, Janabi M, Maboko L, Sandström E, Kroidl A

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania by McCutchan FE, Michael NL, Robb ML, Hoelscher M, Maboko L, Ratto-Kim S, Moqueet N, Bautista CT, Currier JR, Saathoff E, Walsh AM, Koehler RN, Kim JH, Kijak GH

European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research. by Lehner, T, Hoelscher, M, Clerici, M, Gotch, F, Pedneault, L, Tartaglia, J, Gray, C, Mestecky, J, Sattentau, Q, van de Wijgert, J, Toure, C, Osmanov, S, Schmidt, R, Debre, P, Romaris, M, Hoeveler, A, Di Fabio, S

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime by Bauer A, Podola L, Haule A, Sudi L, Nilsson C, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, Joseph S, McCormack S, Lyamuya E, Wahren B, Sandström E, Biberfeld G, Hoelscher M, Kroidl A, Geldmacher C

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen by Podola L, Bauer A, Haule A, Sudi L, Nilsson C, Godoy-Ramirez K, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, McCormack S, Joseph S, Lyamuya E, Hoelscher M, Wahren B, Sandström E, Biberfeld G, Geldmacher C, Kroidl A